Effect of Dual-Task Training on Pediatric Oncology Patients

NCT05118464 | Unknown

• 1 other identifier: 2020/387
• Study Type: interventional
• Target: 21
• Locations: 1 country
• Sites: 1

Brief Summary

It is known that the treatment of children with cancer has negative effects on cognition, muscle strength, balance, and gait. Therefore, the aim of this study is to evaluate the effects of dual-task training, which is based on the principle of simultaneous performance of cognitive tasks and motor tasks, on muscle strength, balance, and gait.

Conditions

Cancer

Keywords

cancer; gait; postural balance; muscle strength

Outcome Measures

Primary Outcomes (3)

• gait speed

  Gait speed is the time one takes to walk a specified distance on level surfaces over a short distance. It will be recorded in m/s.

  600 seconds

• balance

  Balance is evaluated with Timed-up and Go Test. The time elapsed during the test is recorded in seconds.

  300 seconds

• Muscle strength

  Isometric muscle strength will be evaluated with a hand-held dynamometer. It will be recorded in kg.

  600 seconds

Study Arms (1)

Children with cancer

EXPERIMENTAL

The arm of the research will consist of pediatric patients aged 6-18 years who have been diagnosed with cancer in Afyonkarahisar Health Sciences University, Health Application and Research Center, Department of Pediatric Hematology-Oncology Clinics and who come for outpatient treatment.

Other: Dual-task training

Interventions

Dual-task training OTHER

Dual-task training includes simultaneous execution of motor and cognitive tasks. The motor tasks in this study will be walking, going up and downstairs, turning, throwing, and holding a ball. Cognitive tasks will be an n-back test, verbal fluency, remembering sequences of numbers, and performing simple summing.

Children with cancer

Eligibility Criteria

• Age: 6 Years - 18 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Child (0-17), Adult (18-64)

You may qualify if:

• Diagnosed with pediatric cancer and inpatient and outpatient treatment in Hematology-Oncology Clinics for treatment,
• Able to walk alone without any walking aid,
• Children aged 6-18 will be included

You may not qualify if:

• Staying in an isolated room or at risk of infection (neutropenic, etc.),
• Any orthopedic or neurological disorder that may prevent walking;
• Having any mental disability that will prevent performing a cognitive task,
• Individuals with malignant hypertension or unstable heart disease (eg, congestive heart failure) will not be included in the study.

Sponsors & Collaborators

• Afyonkarahisar Health Sciences University: lead

Study Sites (1)

Emel Taşvuran Horata

Afyonkarahisar, 03030, Turkey (Türkiye)

RECRUITING

MeSH Terms

Conditions

Neoplasms

Study Officials

• EMEL TAŞVURAN HORATA, PhD

  AFSU

  PRINCIPAL INVESTIGATOR

Central Study Contacts

EMEL TAŞVURAN HORATA, PhD

CONTACT

+905547759663; ethorata@gmail.com

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: TREATMENT
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: PhD; Assistant Professor

Study Record Dates

• First Submitted: October 31, 2021
• First Posted: November 12, 2021
• Study Start: September 15, 2021
• Primary Completion: September 15, 2022
• Study Completion: September 15, 2023
• Last Updated: November 12, 2021

Record last verified: 2021-11

Data Sharing

• IPD Sharing: Will not share

Locations

TU (1)